Literature DB >> 24756309

Management of Acute Myeloid Leukemia in the Intensive Care Setting.

Andrew J Cowan1, William A Altemeier2, Christine Johnston3, Terry Gernsheimer4, Pamela S Becker5.   

Abstract

Patients with acute myeloid leukemia (AML) who are newly diagnosed or relapsed and those who are receiving cytotoxic chemotherapy are predisposed to conditions such as sepsis due to bacterial and fungal infections, coagulopathies, hemorrhage, metabolic abnormalities, and respiratory and renal failure. These conditions are common reasons for patients with AML to be managed in the intensive care unit (ICU). For patients with AML in the ICU, providers need to be aware of common problems and how to manage them. Understanding the pathophysiology of complications and the recent advances in risk stratification as well as newer therapy for AML are relevant to the critical care provider.
© The Author(s) 2014.

Entities:  

Keywords:  intensive care unit; respiratory failure; subdural hemorrhage; tumor lysis syndrome

Mesh:

Year:  2014        PMID: 24756309     DOI: 10.1177/0885066614530959

Source DB:  PubMed          Journal:  J Intensive Care Med        ISSN: 0885-0666            Impact factor:   3.510


  2 in total

1.  Early mortality and complications in hospitalized adult Californians with acute myeloid leukaemia.

Authors:  Gwendolyn Ho; Brian A Jonas; Qian Li; Ann Brunson; Ted Wun; Theresa H M Keegan
Journal:  Br J Haematol       Date:  2017-04-17       Impact factor: 6.998

2.  The expression of Toll-like receptors and development of severe sepsis in patients with acute myeloid leukemias after induction chemotherapy.

Authors:  Justyna Rybka; Aleksandra Butrym; Tomasz Wróbel; Bożena Jaźwiec; Ewa Stefanko; Olga Dobrzyńska; Rafał Poręba; Kazimierz Kuliczkowski
Journal:  Med Oncol       Date:  2014-11-22       Impact factor: 3.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.